Annual FCF
-$156.57 M
-$33.42 M-27.14%
December 31, 2023
Summary
- As of March 12, 2025, AUTL annual free cash flow is -$156.57 million, with the most recent change of -$33.42 million (-27.14%) on December 31, 2023.
- During the last 3 years, AUTL annual FCF has fallen by -$24.13 million (-18.22%).
- AUTL annual FCF is now -1237.77% below its all-time high of -$11.70 million, reached on September 30, 2016.
Performance
AUTL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$86.33 M
-$34.41 M-66.26%
September 30, 2024
Summary
- As of March 12, 2025, AUTL quarterly free cash flow is -$86.33 million, with the most recent change of -$34.41 million (-66.26%) on September 30, 2024.
- Over the past year, AUTL quarterly FCF has dropped by -$45.28 million (-110.32%).
- AUTL quarterly FCF is now -703.58% below its all-time high of -$10.74 million, reached on December 31, 2021.
Performance
AUTL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$205.61 M
-$44.64 M-27.73%
September 30, 2024
Summary
- As of March 12, 2025, AUTL TTM free cash flow is -$205.61 million, with the most recent change of -$44.64 million (-27.73%) on September 30, 2024.
- Over the past year, AUTL TTM FCF has dropped by -$54.03 million (-35.65%).
- AUTL TTM FCF is now -507.47% below its all-time high of -$33.85 million, reached on March 31, 2019.
Performance
AUTL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AUTL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.1% | -110.3% | -35.6% |
| 3 y3 years | -18.2% | -103.0% | -44.3% |
| 5 y5 years | -546.8% | -103.0% | -44.3% |
AUTL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.1% | at low | -703.6% | at low | -73.4% | at low |
| 5 y | 5-year | -30.3% | at low | -703.6% | at low | -82.0% | at low |
| alltime | all time | -1237.8% | at low | -703.6% | at low | -507.5% | at low |
Autolus Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$86.33 M(+66.3%) | -$205.61 M(+27.7%) |
| Jun 2024 | - | -$51.92 M(+26.5%) | -$160.97 M(+6.2%) |
| Mar 2024 | - | -$41.05 M(+56.0%) | -$151.58 M(-3.2%) |
| Dec 2023 | -$156.57 M(+27.1%) | -$26.31 M(-36.9%) | -$156.57 M(+7.6%) |
| Sep 2023 | - | -$41.69 M(-2.0%) | -$145.46 M(+2.1%) |
| Jun 2023 | - | -$42.54 M(-7.6%) | -$142.48 M(+6.8%) |
| Mar 2023 | - | -$46.04 M(+202.9%) | -$133.39 M(+8.3%) |
| Dec 2022 | -$123.15 M(-2.8%) | -$15.20 M(-60.7%) | -$123.15 M(+3.8%) |
| Sep 2022 | - | -$38.70 M(+15.7%) | -$118.69 M(+0.1%) |
| Jun 2022 | - | -$33.45 M(-6.6%) | -$118.60 M(-3.8%) |
| Mar 2022 | - | -$35.80 M(+233.2%) | -$123.28 M(-2.7%) |
| Dec 2021 | -$126.72 M | -$10.74 M(-72.2%) | -$126.72 M(-15.1%) |
| Sep 2021 | - | -$38.61 M(+1.3%) | -$149.18 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$38.12 M(-2.9%) | -$153.68 M(+6.0%) |
| Mar 2021 | - | -$39.24 M(+18.2%) | -$145.01 M(+9.5%) |
| Dec 2020 | -$132.44 M(+10.2%) | -$33.20 M(-23.0%) | -$132.44 M(-1.5%) |
| Sep 2020 | - | -$43.11 M(+46.4%) | -$134.42 M(+12.4%) |
| Jun 2020 | - | -$29.46 M(+10.4%) | -$119.58 M(+5.8%) |
| Mar 2020 | - | -$26.67 M(-24.2%) | -$112.97 M(-6.0%) |
| Dec 2019 | -$120.15 M(+396.4%) | -$35.18 M(+24.5%) | -$120.15 M(+41.4%) |
| Sep 2019 | - | -$28.27 M(+23.7%) | -$84.97 M(+49.9%) |
| Jun 2019 | - | -$22.86 M(-32.5%) | -$56.70 M(+67.5%) |
| Mar 2019 | - | -$33.85 M | -$33.85 M |
| Dec 2018 | -$24.21 M(-41.1%) | - | - |
| Sep 2018 | -$41.07 M(+113.5%) | - | - |
| Sep 2017 | -$19.24 M(+64.4%) | - | - |
| Sep 2016 | -$11.70 M | - | - |
FAQ
- What is Autolus Therapeutics annual free cash flow?
- What is the all time high annual FCF for Autolus Therapeutics?
- What is Autolus Therapeutics annual FCF year-on-year change?
- What is Autolus Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly FCF year-on-year change?
- What is Autolus Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Autolus Therapeutics?
- What is Autolus Therapeutics TTM FCF year-on-year change?
What is Autolus Therapeutics annual free cash flow?
The current annual FCF of AUTL is -$156.57 M
What is the all time high annual FCF for Autolus Therapeutics?
Autolus Therapeutics all-time high annual free cash flow is -$11.70 M
What is Autolus Therapeutics annual FCF year-on-year change?
Over the past year, AUTL annual free cash flow has changed by -$33.42 M (-27.14%)
What is Autolus Therapeutics quarterly free cash flow?
The current quarterly FCF of AUTL is -$86.33 M
What is the all time high quarterly FCF for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly free cash flow is -$10.74 M
What is Autolus Therapeutics quarterly FCF year-on-year change?
Over the past year, AUTL quarterly free cash flow has changed by -$45.28 M (-110.32%)
What is Autolus Therapeutics TTM free cash flow?
The current TTM FCF of AUTL is -$205.61 M
What is the all time high TTM FCF for Autolus Therapeutics?
Autolus Therapeutics all-time high TTM free cash flow is -$33.85 M
What is Autolus Therapeutics TTM FCF year-on-year change?
Over the past year, AUTL TTM free cash flow has changed by -$54.03 M (-35.65%)